logo
Up 909% in 3 years! Can Rolls-Royce shares carry on climbing?

Up 909% in 3 years! Can Rolls-Royce shares carry on climbing?

Yahoo2 days ago

Rolls-Royce Holdings (LSE: RR.) shares have had another strong month, climbing 8.6%. Over the last year, they're up more than 85%, but it's the three-year performance that really takes the breath away — up 909%.
If an investor had caught this stock just right in June 2022, when it was still struggling, they'd have turned £10,000 into £100,900. That sort of growth can transform retirement plans and shows the sheer potential of individual share picking over passively tracking the market.
Of course, picking a transformation stock like this isn't easy. They're rare and tough to spot. Oddly enough, I did spot the turnaround story and bought Rolls-Royce back in October 2022. Sadly, I didn't transfer my retirement plans. But I was short of cash so only took a small position and chose to bank my 175% gain after a year when I needed some ready money.
That looked like the top to me, so I took the profit. But the shares kept climbing. I bought back in twice last August at an average of 485p. With the price at 872.8p today, that late trade is still showing a gain of around 80%.
On 10 June, the UK government confirmed its backing for Rolls-Royce's small modular nuclear reactors. This adds yet another potential revenue stream, although Rolls needs other countries to come on board.
The company's latest trading update on 1 May showed a strong start to 2025, and it stood by its 2025 guidance of £2.7bn to £2.9bn of underlying operating profit.
Large engine flying hours in Civil Aerospace hit 110% of pre-Covid levels. In Defence, demand remains robust. Power Systems is thriving. The firm has also completed £138m of its £1bn share buyback programme. It doesn't seem so long ago that net debt was the big worry here. Not now though.
Rolls-Royce now trades on a price-to-earnings ratio of 44, which is expensive. Despite its stellar success, this isn't a risk-free business.
Civil Aerospace depends on global travel demand. Any disruption, from economic downturns to geopolitical events, could hit engine orders and servicing revenue.
Power Systems is booming right now, but if demand from data centres drops, so could growth. The group is still under pressure to deliver its transformation under CEO Tufan Erginbilgic. Any missed milestones would raise doubts.
The 12 analysts offering one-year share price forecasts have produced a median target of 859.6p. If correct, that's a small drop of around 1% from today's price.
Despite that, of the 14 analysts offering stock ratings, 10 call it a Strong Buy. Two say Hold, two say Sell. So confidence in the long-term growth story remains strong.
The pace of gains will almost certainly slow from here. A profit shortfall would do it. But I still think the transformation story has legs.
Since investors can't buy at the old price, those considering the stock have to accept paying the new higher one. I'd think it's still worth considering, possibly drip-feeding into the stock to take advantage of any dips.
The post Up 909% in 3 years! Can Rolls-Royce shares carry on climbing? appeared first on The Motley Fool UK.
More reading
5 Stocks For Trying To Build Wealth After 50
One Top Growth Stock from the Motley Fool
Harvey Jones has positions in Rolls-Royce Plc. The Motley Fool UK has recommended Rolls-Royce Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
Motley Fool UK 2025

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Third of businesses planning further job cuts after national insurance hikes
Third of businesses planning further job cuts after national insurance hikes

Yahoo

time32 minutes ago

  • Yahoo

Third of businesses planning further job cuts after national insurance hikes

A third of business owners have said they plan to cut more jobs after being hit by higher national insurance contributions (NICs) in April, according to new research. Many companies have also suggested they will cut back hours, freeze pay and hike prices in order to help cover increased tax payments. S&W's business owners sentiment survey revealed around 20% of those quizzed said they have already reduced their staff numbers as a 'direct result' of the NICs changes which came into effect in April. Last year, Chancellor Rachel Reeves announced in her autumn budget that employers' NICs would rise from 13.8% to 15%, while the threshold at which firms would start paying also increased. The increase came in at the same time as the jump in the national living wage and reduced business rates relief for some firms. The survey found 33% of business owners said they were still planning further cuts to staff numbers after feeling the impact of the tax increase. Firms said they were also looking to a series of other measures in order to offset the jump in their operating costs. The survey of 500 UK business owners with turnovers of £5 million upwards also showed 46% of those surveyed said they were planning further price increases as a result. Meanwhile, 35% of business owners said they planned to reduce staff hours and 29% said they were looking at freezing pay. It comes as firms highlighted higher commodity and energy costs, as well as disruption from wider macroeconomic uncertainty. Claire Burden, partner in consulting at S&W, said: 'Businesses face considerable challenges in the current economic climate and many owners are having to make difficult decisions to stay afloat. 'Given that salaries represent a considerable proportion of the overall cost base for most businesses, it is to be expected that many are looking closely at headcounts in response to the increased national insurance costs.' Alex Simpson, partner in employer solutions at S&W, said: 'For most businesses, the extent of the employers' NIC change was a surprise. 'We anticipated an increase in the employers' rate, but the additional reduction to the earnings threshold was not expected and is expected to have a dramatic impact over time.' A Government spokesman said: 'We are a pro-business government. We are protecting the smallest businesses from the employer national insurance rise, shielding 250,000 retail, hospitality and leisure business properties from paying full business rates and have capped corporation tax. 'We delivered a once-in-a-Parliament budget last year that took necessary decisions on tax to stabilise the public finances, including the NHS which has now seen waiting lists fall five months in a row. 'We are now focused on creating opportunities for businesses to compete and access the finance they need to scale, export and break into new markets.'

The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D
The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D

Forbes

time32 minutes ago

  • Forbes

The UK Must Bridge Funding Gaps To Position Itself As Hub For R&D

Innovation needs a new safe haven and while the UK has all the building blocks to be that place, to make it happen we need to ensure that our ambition translates into delivery. The UK's latest research and development funding settlement has reignited a familiar tension of long-term ambition versus short-term constraint. CaSE has cautioned that the government's £8.8 billion funding allocation to UK Research and Innovation (UKRI) essentially amounts to a flat-cash settlement. Along with inflation and rising operating costs this means less room for new investment – forcing harder choices at a time when our ambitions to become a global hotspot for science depend on sustained momentum. The recent announcement of 10-year budgets for R&D funding is a welcome signal of long-term intent and offers a degree of clarity that industry and academia alike have long called for. However, visibility alone is not the same as increased investment. Unless these budgets translate into real-terms growth, the UK risks falling behind its global competitors. However, disruption in the global R&D landscape and notably the US, presents an opportunity. If we act swiftly and work strategically, the UK can position itself as a stable, globally attractive home for international talent and industry investment. But this must be matched by real-world readiness. Preparing for change In the US, proposals to significantly reduce budgets for key agencies like the National Institute of Health and National Science Foundation have raised alarm. Coupled with a rise in anti-vaccine rhetoric and scientists facing budget-cuts overnight, we're seeing an environment emerge that may stifle talent rather than nurture it. I – and many others – will also be keeping an ear to the ground as we continue to await a decision around pharma tariffs. While we're not expecting a mass exodus out of the US, it would be naïve to think that in this climate, talent couldn't be tempted elsewhere. To attract these internationally mobile innovators, tech entrepreneurs, engineers and scientists, we need to prove that the welcome mat is out, and the funding tap is on. That's where innovation clusters can play a vital role. Back in 2021, QIAGEN, a global diagnostics company from Germany, established its Global Centre of Excellence for Precision Medicine at Bruntwood SciTech's Citylabs 2.0, where it now actively partners with the NHS to accelerate healthcare breakthroughs. More recently, US pharmaceutical giant Eli Lilly began a five-year trial into the effectiveness of weight loss drug Tirzepatide on the job prospects of people living with obesity in Greater Manchester. The trial is being run by Health Innovation Manchester in partnership with Eli Lilly, along with the University of Manchester and local digital trials company NorthWest EHealth. And at a time when commercial clinical trial recruitment is in decline, Greater Manchester is bucking the trend, driven by a good relationship with the patient population, strong research infrastructure, a talented workforce and collaboration between providers, businesses, academia and industry. That is to say, while the national funding picture remains tight, we're seeing regional hubs across the UK stepping up. Regional strength equals international advantage A well-known challenge for new start-ups, especially within technology and innovation, is attracting early-stage investment. We need to see improved funding in areas away from the more traditional locations of London and South East England, that can attract young companies and new talent – both nationally and internationally. As such, we welcome the Government's latest commitment to provide £500 million for regions across the UK to make decisions around how to boost R&D in a way that is most appropriate for them. Innovation hubs in cities like Manchester, Birmingham and Leeds are helping to maintain momentum despite national funding pressures. These places are building internationally connected clusters underpinned by strong partnerships between academia, industry and the public sector. In Manchester, for example, the recently opened Citylabs 4.0 provides new specialist lab and office space on Europe's largest clinical-academic campus, supporting life sciences research and strengthening collaboration with the NHS. Meanwhile, in Leeds, a wave of activity is strengthening the city's profile as a destination for innovative, high-growth businesses. Iconic British broadcaster Channel 4, Yorkshire Bank and international energy and services company Centrica all have significant operations in the city, attracted by its growing financial services cluster, collaborative tech ecosystem and access to skilled talent. However, we're seeing competition across the EU to attract internationally mobile talent and businesses in the sector. The European Commission recently unveiled its 'Choose Europe' scheme to promote the region as a world-leading centre of research, innovation and scientific freedom – including a €500 million pledge for 2025-27, to make Europe a 'magnet' for researchers. To draw top-tier talent and investment then, we need to double-down on what makes the UK standout. That is, openness to collaboration, strength in diversity of research and a unique blend of regionally driven infrastructure and ecosystem support. The government's commitment to UKRI is a signal of ambition but flat cash won't be enough to stay ahead. If we're serious about being a superpower of tech, innovation and science, now is the time to act. That means ensuring real-term investment to support our regional powerhouses and showing the world that we are the most attractive, stable home for the next generation of global innovation.

IDEX Biometrics ASA: Registration of share capital increase
IDEX Biometrics ASA: Registration of share capital increase

Yahoo

time37 minutes ago

  • Yahoo

IDEX Biometrics ASA: Registration of share capital increase

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 April 2025 regarding the 11 April 2025 Extraordinary General Meeting's resolution to carry out a subsequent offering by issuance of up to 600,000,000 new shares in the Company. Reference is also made to the announcement on 6 June 2025 regarding the subsequent offering being 8x oversubscribed, resulting in the issuance of 600,000,000 new shares at a subscription price per share of NOK 0.01, raising gross proceeds of NOK 6 million. The share capital increase has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increase, the Company's share capital is NOK 44,316,309.99 divided into 4,431,630,999 shares, each with a nominal value of NOK 0.01. For further information contact: Kristian Flaten, CFO E-mail: ir@ Tel: +47 95092322 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice This notice was published by Kristian Flaten, CFO, 17 June 2025 at 10:42 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store